Search results
Results From The WOW.Com Content Network
An indication can commonly be confused with the term diagnosis. A diagnosis is the assessment that a particular medical condition is present while an indication is a reason for use. [3] The opposite of an indication is a contraindication, [4] a reason to withhold a certain medical treatment because the risks of treatment clearly outweigh the ...
In medicine, a contraindication is a condition (a situation or factor) that serves as a reason not to take a certain medical treatment due to the harm that it would cause the patient. [1][2] Contraindication is the opposite of indication, which is a reason to use a certain treatment. Absolute contraindications are contraindications for which ...
Leuprorelin. Leuprorelin, also known as leuprolide, is a manufactured version of a hormone used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids, for early puberty, or as part of transgender hormone therapy. [10][11] It is given by injection into a muscle or under the skin. [10]
Raloxifene, sold under the brand name Evista among others, is a medication used to prevent and treat osteoporosis in postmenopausal women and those on glucocorticoids. [6] For osteoporosis it is less preferred than bisphosphonates. [6] It is also used to reduce the risk of breast cancer in those at high risk. [6]
Labetalol is a medication used to treat high blood pressure and in long term management of angina. [4][5] This includes essential hypertension, hypertensive emergencies, and hypertension of pregnancy. [5] In essential hypertension it is generally less preferred than a number of other blood pressure medications. [4]
Boxed warning. An exemplary boxed warning, as seen in context, in FDA's Challenges and Issues with Safety-Related Information in the Prescribing Information slide desk. For emphasis, the text is bolded and surrounded by a black outline. In the United States, a boxed warning (sometimes " black box warning ", colloquially) is a type of warning ...
Dostarlimab is a monoclonal antibody that binds to PD-1 to block it from binding PD-1 ligands to remove inhibition of immune response. [5] With this, it causes risk for immune-mediated adverse reactions. [5] These reactions can be severe or fatal and occur in any part of the body: organs or tissues. [5]
Levosimendan is a calcium sensitizer — it increases the sensitivity of the heart to calcium, thus increasing cardiac contractility without a rise in intracellular calcium. Levosimendan exerts its positive inotropic effect by increasing calcium sensitivity of myocytes by binding to cardiac troponin C in a calcium-dependent manner.